Trial title not recorded
Intracerebral Hemorrhage
Enrolment: 110 · Results not recorded
Drug · JAK1/JAK2 inhibitor.
1 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Intracerebral Hemorrhage
Enrolment: 110 · Results not recorded
COVID19
Enrolment: 1167 · Results not recorded
Rheumatoid Arthritis
Enrolment: 60 · Results not recorded
Psoriasis
Enrolment: 271 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Acute spinal cord injury in rats
The baricitinib hydrogel inhibited JAK2 and STAT3 phosphorylation, suppressed inflammatory cytokines and reduced neuronal apoptosis early after injury, and later promoted functional recovery.
Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.